{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T04:30:53Z","timestamp":1790397053759,"version":"4.1.0"},"reference-count":79,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2013,1,1]],"date-time":"2013-01-01T00:00:00Z","timestamp":1356998400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neuroscience"],"published-print":{"date-parts":[[2013,1]]},"DOI":"10.1016\/j.neuroscience.2012.10.026","type":"journal-article","created":{"date-parts":[[2012,10,22]],"date-time":"2012-10-22T16:15:49Z","timestamp":1350922549000},"page":"200-214","source":"Crossref","is-referenced-by-count":37,"special_numbering":"C","title":["Acute N-methyl-d-aspartate receptor hypofunction induced by MK801 evokes sex-specific changes in behaviors observed in open-field testing in adult male and proestrus female rats"],"prefix":"10.1016","volume":"228","author":[{"given":"I.","family":"Feinstein","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.F.","family":"Kritzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuroscience.2012.10.026_b0005","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1093\/schbul\/sbr133","article-title":"Is the acute NMDA receptor hypofunction a valid model of schizophrenia?","volume":"38","author":"Adell","year":"2012","journal-title":"Schizophr Bull"},{"key":"10.1016\/j.neuroscience.2012.10.026_b0010","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1016\/S0022-3565(24)35047-5","article-title":"Characterization of MK-801-induced behavior as a putative rat model of psychosis","volume":"290","author":"Andine","year":"1999","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.neuroscience.2012.10.026_b0015","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.biopsych.2008.01.003","article-title":"The role of the cerebellum in schizophrenia","volume":"64","author":"Andreasen","year":"2008","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.neuroscience.2012.10.026_b0020","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.bbr.2009.04.006","article-title":"Modeling cholinergic aspects of schizophrenia: focus on the antimuscarinic syndrome","volume":"204","author":"Barak","year":"2009","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.neuroscience.2012.10.026_b0025","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/0014-2999(82)90178-9","article-title":"Sex differences and estrous cycle variations in amphetamine-elicited rotational behavior","volume":"80","author":"Becker","year":"1982","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.neuroscience.2012.10.026_b0030","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/BF01250962","article-title":"MK-801 induced stereotypies in rats are decreased by haloperidol and increased by diazepam","volume":"90","author":"Behrens","year":"1992","journal-title":"J Neural Transm Gen Sect"},{"key":"10.1016\/j.neuroscience.2012.10.026_b0035","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1016\/j.neuropharm.2006.11.004","article-title":"The opposite effect of a low and a high dose of serotonin-1A agonist on behavior induced by MK-801","volume":"52","author":"Bubenikova-Valesova","year":"2007","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuroscience.2012.10.026_b0040","first-page":"178","article-title":"Gender and schizophrenia","volume":"40","author":"Canuso","year":"2007","journal-title":"Psychopharmacol Bull"},{"key":"10.1016\/j.neuroscience.2012.10.026_b0045","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/s002130050616","article-title":"Effects of dizocilpine (MK-801) on motor activity and memory","volume":"137","author":"Carey","year":"1998","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuroscience.2012.10.026_b0050","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s00213-003-1710-9","article-title":"Animal models of working memory: insights for targeting cognitive dysfunction in schizophrenia","volume":"174","author":"Castner","year":"2004","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuroscience.2012.10.026_b0055","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/0091-3057(95)00072-5","article-title":"Clozapine but not haloperidol antagonizes an MK-801 discriminative stimulus cue","volume":"51","author":"Corbett","year":"1995","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.neuroscience.2012.10.026_b0060","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.schres.2009.07.002","article-title":"Gender differences in premorbid, entry, treatment, and outcome characteristics in a treated epidemiological sample of 661 patients with first episode psychosis","volume":"114","author":"Cotton","year":"2009","journal-title":"Schizophr Res"},{"key":"10.1016\/j.neuroscience.2012.10.026_b0065","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/BF02246176","article-title":"Effect of NMDA receptor antagonists on D1, D2 and D1\/D2 mediated behaviors in intact rats","volume":"123","author":"Dall\u2019Olio","year":"1996","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuroscience.2012.10.026_b0070","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/0091-3057(94)90506-1","article-title":"Glutamate antagonists have different effects on spontaneous locomotor activity in rats","volume":"48","author":"Danysz","year":"1994","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.neuroscience.2012.10.026_b0075","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0741-8329(02)00326-9","article-title":"Effects of ethanol or rimcazole on dizocilpine maleate-induced behaviors in male and female rats","volume":"29","author":"Devaud","year":"2003","journal-title":"Alcohol"},{"key":"10.1016\/j.neuroscience.2012.10.026_b0080","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0741-8329(02)00239-2","article-title":"Altered responses to dizocilpine maleate administration in ethanol-withdrawn male and female rats","volume":"28","author":"Devaud","year":"2002","journal-title":"Alcohol"},{"key":"10.1016\/j.neuroscience.2012.10.026_b0085","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.bbr.2010.07.031","article-title":"Reciprocal interactions between MK-801, sleep deprivation and recovery in modulating rat behaviour","volume":"216","author":"Dubiela","year":"2011","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.neuroscience.2012.10.026_b0090","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0014-2999(89)90811-X","article-title":"Effects of 5-HT1A receptor agonists and NMDA receptor antagonists in the social interaction test and the elevated plus maze","volume":"169","author":"Dunn","year":"1989","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.neuroscience.2012.10.026_b0400","first-page":"CD006197","article-title":"Testosterone for schizophrenia","author":"Elias","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.neuroscience.2012.10.026_b0100","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/0165-0173(94)00014-G","article-title":"The N-methyl-d-aspartate antagonists phencyclidine, ketamine and dizocilpine as both behavioral and anatomical models of the dementias","volume":"20","author":"Ellison","year":"1995","journal-title":"Brain Res Brain Res Rev"},{"key":"10.1016\/j.neuroscience.2012.10.026_b0105","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-3-642-83797-5_1","article-title":"Neurobiology of reproduction in the female rat. A fifty-year perspective","volume":"32","author":"Everett","year":"1989","journal-title":"Monogr Endocrinol"},{"key":"10.1016\/j.neuroscience.2012.10.026_b0110","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1016\/j.pnpbp.2007.08.025","article-title":"The amphetamine-induced sensitized state as a model of schizophrenia","volume":"31","author":"Featherstone","year":"2007","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.neuroscience.2012.10.026_b0115","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0014-2999(99)00070-9","article-title":"Locomotion elicited by MK801 in developing and adult rats: temporal, environmental, and gender effects","volume":"369","author":"Frantz","year":"1999","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.neuroscience.2012.10.026_b0120","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/s00213-002-1311-z","article-title":"Systemic administration of MK-801 produces an abnormally persistent latent inhibition which is reversed by clozapine but not haloperidol","volume":"166","author":"Gaisler-Salomon","year":"2003","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuroscience.2012.10.026_b0125","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/BF01294789","article-title":"Effects of zotepine, haloperidol and clozapine on MK-801-induced stereotypy and locomotion in rats","volume":"96","author":"Gattaz","year":"1994","journal-title":"J Neural Transm Gen Sect"},{"key":"10.1016\/j.neuroscience.2012.10.026_b0130","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/BF03033358","article-title":"The family of sensorimotor gating disorders: comorbidities or diagnostic overlaps?","volume":"10","author":"Geyer","year":"2006","journal-title":"Neurotox Res"},{"key":"10.1016\/j.neuroscience.2012.10.026_b0135","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s002130100811","article-title":"Pharmacological studies of prepulse inhibition models of sensorimotor gating deficits in schizophrenia: a decade in review","volume":"156","author":"Geyer","year":"2001","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuroscience.2012.10.026_b0140","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1002\/bdrb.20106","article-title":"The rodent estrous cycle: characterization of vaginal cytology and its utility in toxicological studies","volume":"80","author":"Goldman","year":"2007","journal-title":"Birth Defects Res B"},{"key":"10.1016\/j.neuroscience.2012.10.026_b0145","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0165-1781(02)00028-8","article-title":"Sex differences in clinical response to olanzapine compared with haloperidol","volume":"110","author":"Goldstein","year":"2002","journal-title":"Psychiatry Res"},{"key":"10.1016\/j.neuroscience.2012.10.026_b0150","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.physbeh.2009.11.005","article-title":"Effect of testing conditions on the propsychotic action of MK-801 on prepulse inhibition, social behaviour and locomotor activity","volume":"99","author":"Gururajan","year":"2010","journal-title":"Physiol Behav"},{"key":"10.1016\/j.neuroscience.2012.10.026_b0155","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF01245347","article-title":"Typical and atypical neuroleptics antagonize MK-801-induced locomotion and stereotypy in rats","volume":"89","author":"Hoffman","year":"1992","journal-title":"J Neural Transm Gen Sect"},{"key":"10.1016\/j.neuroscience.2012.10.026_b0160","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/0006-8993(93)90287-W","article-title":"Sex differences in NMDA receptor mediated responses in rats","volume":"620","author":"Honack","year":"1993","journal-title":"Brain Res"},{"key":"10.1016\/j.neuroscience.2012.10.026_b0170","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1176\/ajp.148.10.1301","article-title":"Recent advances in the phencyclidine model of schizophrenia","volume":"148","author":"Javitt","year":"1991","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.neuroscience.2012.10.026_b0165","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/S0006-3223(98)00237-6","article-title":"A.E. Bennett Research Award. Reversal of phencyclidine-induced effects by glycine and glycine transport inhibitors","volume":"45","author":"Javitt","year":"1999","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.neuroscience.2012.10.026_b0175","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0893-133X(98)00060-8","article-title":"The neuropsychopharmacology of phencyclidine: from NMDA receptor hypofunction to the dopamine hypothesis of schizophrenia","volume":"20","author":"Jentsch","year":"1999","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuroscience.2012.10.026_b0180","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1111\/j.1476-5381.2011.01386.x","article-title":"Animal models of schizophrenia","volume":"164","author":"Jones","year":"2011","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.neuroscience.2012.10.026_b0185","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1124\/jpet.102.046987","article-title":"Antipsychotic dosing in preclinical models is often unrepresentative of the clinical condition: a suggested solution based on in vivo occupancy","volume":"305","author":"Kapur","year":"2003","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.neuroscience.2012.10.026_b0190","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/1471-244X-12-17","article-title":"Cortico-cerebellar functional connectivity and sequencing of movements in schizophrenia","volume":"12","author":"Kasparek","year":"2012","journal-title":"BMC Psychiatry"},{"key":"10.1016\/j.neuroscience.2012.10.026_b0195","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.psyneuen.2007.02.002","article-title":"Association between serum testosterone levels and the severity of negative symptoms in male patients with chronic schizophrenia","volume":"32","author":"Ko","year":"2007","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.neuroscience.2012.10.026_b0200","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1097\/JCP.0b013e31817d5912","article-title":"Short-term testosterone augmentation in male schizophrenics: a randomized, double-blind, placebo-controlled trial","volume":"28","author":"Ko","year":"2008","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.neuroscience.2012.10.026_b0210","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1001\/archpsyc.1994.03950030035004","article-title":"Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses","volume":"51","author":"Krystal","year":"1994","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.neuroscience.2012.10.026_b0205","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1001\/archpsyc.59.7.663","article-title":"Effects of NMDA receptor antagonists: implications for the pathophysiology of schizophrenia","volume":"59","author":"Krystal","year":"2002","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.neuroscience.2012.10.026_b0215","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1097\/YCO.0b013e328350360e","article-title":"Hormones and schizophrenia","volume":"25","author":"Kulkarni","year":"2012","journal-title":"Curr Opin Psychiatry"},{"key":"10.1016\/j.neuroscience.2012.10.026_b0220","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1177\/0269881110387839","article-title":"Effect of antipsychotics on spontaneous hyperactivity and hypersensitivity to MK-801-induced hyperactivity in rats prenatally exposed to methylazoxymethanol","volume":"25","author":"Le Pen","year":"2011","journal-title":"J Psychopharmacol"},{"key":"10.1016\/j.neuroscience.2012.10.026_b0225","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.0065-1591.2000.0ap25.x","article-title":"Sex differences in schizophrenia, a review of the literature","volume":"401","author":"Leung","year":"2000","journal-title":"Acta Psychiatr Scand Suppl"},{"key":"10.1016\/j.neuroscience.2012.10.026_b0235","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.bbr.2009.01.031","article-title":"Gestational methylazoxymethanol acetate administration: a developmental disruption model of schizophrenia","volume":"204","author":"Lodge","year":"2009","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.neuroscience.2012.10.026_b0230","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/0165-6147(90)90323-Z","article-title":"Noncompetitive excitatory amino acid receptor antagonists","volume":"11","author":"Lodge","year":"1990","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.neuroscience.2012.10.026_b0240","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/0014-2999(92)90029-4","article-title":"The behavioural effects of MK-801 in rats: involvement of dopaminergic, serotonergic and noradrenergic systems","volume":"215","author":"Loscher","year":"1992","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.neuroscience.2012.10.026_b0245","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/S0006-3223(96)00546-X","article-title":"Clozapine blunts N-methyl-d-aspartate antagonist-induced psychosis: a study with ketamine","volume":"42","author":"Malhotra","year":"1997","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.neuroscience.2012.10.026_b0250","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1590\/S1519-69842002000400008","article-title":"Determination of the estrous cycle phases of rats: some helpful considerations","volume":"62","author":"Marcondes","year":"2002","journal-title":"Braz J Biol"},{"key":"10.1016\/j.neuroscience.2012.10.026_b0255","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.cpr.2010.09.002","article-title":"Avolition and expressive deficits capture negative symptom phenomenology: implications for DSM-5 and schizophrenia research","volume":"31","author":"Messinger","year":"2011","journal-title":"Clin Psychol Rev"},{"key":"10.1016\/j.neuroscience.2012.10.026_b0260","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1126\/science.281.5381.1349","article-title":"Reversal of phencyclidine effects by a group II metabotropic glutamate receptor agonist in rats","volume":"281","author":"Moghaddam","year":"1998","journal-title":"Science"},{"key":"10.1016\/j.neuroscience.2012.10.026_b0265","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1007\/s00213-006-0409-0","article-title":"Greater vulnerability to the amnestic effects of ketamine in males","volume":"187","author":"Morgan","year":"2006","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuroscience.2012.10.026_b0270","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/0014-2999(84)90610-1","article-title":"Role of sex hormones in sex-dependent differences in phencyclidine-induced stereotyped behaviors in rats","volume":"105","author":"Nabeshima","year":"1984","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.neuroscience.2012.10.026_b0275","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1017\/S204579601100062X","article-title":"Beyond the facts in schizophrenia: closing the gaps in diagnosis, pathophysiology, and treatment","volume":"20","author":"Nasrallah","year":"2011","journal-title":"Epidemiol Psychiatr Sci"},{"key":"10.1016\/j.neuroscience.2012.10.026_b0280","first-page":"375","article-title":"Preferential blockade by clozapine of hyperlocomotion induced by non-competitive NMDA antagonist MK-801","volume":"42","author":"Ninan","year":"1998","journal-title":"Indian J Physiol Pharmacol"},{"key":"10.1016\/j.neuroscience.2012.10.026_b0285","first-page":"1","article-title":"Gender differences in schizophrenia and first-episode psychosis: A comprehensive literature review","volume":"2012","author":"Ochoa","year":"2012","journal-title":"Schizophr Res Treat"},{"key":"10.1016\/j.neuroscience.2012.10.026_b0290","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1038\/sj.npp.1380103","article-title":"Phencyclidine- and dizocilpine-induced hyperlocomotion are differentially mediated","volume":"11","author":"Ogren","year":"1994","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuroscience.2012.10.026_b0295","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/S0022-3956(99)00029-1","article-title":"NMDA receptor hypofunction model of schizophrenia","volume":"33","author":"Olney","year":"1999","journal-title":"J Psychiatr Res"},{"key":"10.1016\/j.neuroscience.2012.10.026_b0300","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.bbr.2009.04.021","article-title":"Prepulse inhibition and genetic mouse models of schizophrenia","volume":"204","author":"Powell","year":"2009","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.neuroscience.2012.10.026_b0305","doi-asserted-by":"crossref","first-page":"7744","DOI":"10.1073\/pnas.84.21.7744","article-title":"3H-labeled MK-801 binding to the excitatory amino acid receptor complex from rat brain is enhanced by glycine","volume":"84","author":"Reynolds","year":"1987","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.neuroscience.2012.10.026_b0310","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/BF02249408","article-title":"Different behavioral effects of haloperidol, clozapine and thioridazine in a concurrent lever pressing and feeding procedure","volume":"125","author":"Salamone","year":"1996","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuroscience.2012.10.026_b0315","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/0022-510X(93)90063-5","article-title":"Determination of serum and brain concentrations of neuroprotective and non-neuroprotective doses of MK-801","volume":"115","author":"Schwartz","year":"1993","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.neuroscience.2012.10.026_b0320","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1017\/S1461145708008432","article-title":"Prefrontal cortex lesions cause only minor effects on the hyperlocomotion induced by MK-801 and its reversal by clozapine","volume":"11","author":"Scorza","year":"2008","journal-title":"Int J Neuropsychopharmacol"},{"key":"10.1016\/j.neuroscience.2012.10.026_b0325","doi-asserted-by":"crossref","first-page":"571","DOI":"10.2217\/17455057.2.4.571","article-title":"Estrogen, schizophrenia and neurodevelopment","volume":"2","author":"Seeman","year":"2006","journal-title":"Womens Health (Lond Engl)"},{"key":"10.1016\/j.neuroscience.2012.10.026_b0330","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1111\/j.1600-0447.2011.01822.x","article-title":"Menstrual exacerbation of schizophrenia symptoms","volume":"125","author":"Seeman","year":"2012","journal-title":"Acta Psychiatr Scand"},{"key":"10.1016\/j.neuroscience.2012.10.026_b0335","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0920-9964(01)00367-X","article-title":"Correlation of plasma neurosteroid levels to the severity of negative symptoms in male patients with schizophrenia","volume":"58","author":"Shirayama","year":"2002","journal-title":"Schizophr Res"},{"key":"10.1016\/j.neuroscience.2012.10.026_b0340","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1097\/00008877-200006000-00002","article-title":"Animal models of deficient sensorimotor gating: what we know, what we think we know, and what we hope to know soon","volume":"11","author":"Swerdlow","year":"2000","journal-title":"Behav Pharmacol"},{"key":"10.1016\/j.neuroscience.2012.10.026_b0345","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/0006-3223(95)00138-7","article-title":"Gender differences in neuroleptic nonresponsive clozapine-treated schizophrenics","volume":"39","author":"Szymanski","year":"1996","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.neuroscience.2012.10.026_b0350","first-page":"3","article-title":"Evaluation of serum steroid hormones in schizophrenic patients","volume":"58","author":"Taherianfard","year":"2004","journal-title":"Indian J Med Sci"},{"key":"10.1016\/j.neuroscience.2012.10.026_b0355","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/BF01245040","article-title":"MK-801-induced stereotypy and its antagonism by neuroleptic drugs","volume":"81","author":"Tiedtke","year":"1990","journal-title":"J Neural Transm Gen Sect"},{"key":"10.1016\/j.neuroscience.2012.10.026_b0360","doi-asserted-by":"crossref","first-page":"208","DOI":"10.3371\/CSRP.5.4.5","article-title":"Adjunct treatments for schizophrenia and bipolar disorder: what to try when you are out of ideas","volume":"5","author":"Torrey","year":"2012","journal-title":"Clin Schizophr Relat Psychoses"},{"key":"10.1016\/j.neuroscience.2012.10.026_b0365","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/0091-3057(88)90413-3","article-title":"Thigmotaxis as a test for anxiolytic activity in rats","volume":"31","author":"Treit","year":"1988","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.neuroscience.2012.10.026_b0370","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.psychres.2006.09.016","article-title":"Gender differences in response to antipsychotic treatment in outpatients with schizophrenia","volume":"153","author":"Usall","year":"2007","journal-title":"Psychiatry Res"},{"key":"10.1016\/j.neuroscience.2012.10.026_b0375","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1093\/schbul\/sbp132","article-title":"Modeling the positive symptoms of schizophrenia in genetically modified mice: pharmacology and methodology aspects","volume":"36","author":"van den Buuse","year":"2010","journal-title":"Schizophr Bull"},{"key":"10.1016\/j.neuroscience.2012.10.026_b0380","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/S0022-3565(25)23251-7","article-title":"Kinetics of MK-801 and its effect on quinolinic acid-induced seizures and neurotoxicity in rats","volume":"249","author":"Vezzani","year":"1989","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.neuroscience.2012.10.026_b0385","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.neulet.2011.08.012","article-title":"Evaluation of brain pharmacokinetics of (+)MK-801 in relation to behaviour","volume":"503","author":"Wegener","year":"2011","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.neuroscience.2012.10.026_b0390","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.physbeh.2007.02.010","article-title":"Effects of age and sex on ketamine-induced hyperactivity in rats","volume":"91","author":"Wilson","year":"2007","journal-title":"Physiol Behav"},{"key":"10.1016\/j.neuroscience.2012.10.026_b0395","doi-asserted-by":"crossref","first-page":"5372","DOI":"10.1073\/pnas.76.10.5372","article-title":"Specific [3H]phencyclidine binding in rat central nervous system","volume":"76","author":"Zukin","year":"1979","journal-title":"Proc Natl Acad Sci USA"}],"container-title":["Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306452212010342?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306452212010342?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,17]],"date-time":"2025-04-17T21:40:48Z","timestamp":1744926048000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306452212010342"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1]]},"references-count":79,"alternative-id":["S0306452212010342"],"URL":"https:\/\/doi.org\/10.1016\/j.neuroscience.2012.10.026","relation":{},"ISSN":["0306-4522"],"issn-type":[{"value":"0306-4522","type":"print"}],"subject":[],"published":{"date-parts":[[2013,1]]}}}